Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Kcnq2em1/Cya
Common Name:
Kcnq2-KO
Product ID:
S-KO-16937
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Kcnq2-KO
Strain ID
KOCMP-16536-Kcnq2-B6J-VA
Gene Name
Kcnq2
Product ID
S-KO-16937
Gene Alias
HNSPC; KQT2; Nmf134
Background
C57BL/6JCya
NCBI ID
16536
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:1309503
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Kcnq2em1/Cya mice (Catalog S-KO-16937) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000149964
NCBI RefSeq
NM_010611
Target Region
Exon 2~5
Size of Effective Region
~3.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Kcnq2 encodes the Kv7.2 channel subunit. The human voltage-gated potassium channel KCNQ2/KCNQ3 carries the neuronal M-current, which helps to stabilize the membrane potential [2]. Kcnq2-related channels have emerged as a target for novel antiepileptic drugs as their activation could reduce epileptic activity [4]. Mouse models have been developed to study Kcnq2-related pathological mechanisms [1].

Variants in Kcnq2 cause epileptic disorders, ranging from benign forms with self-limited seizures and normal development to severe forms with intractable seizures and encephalopathy [1]. The severe form remains intractable in patients. In Kcnq2-related epilepsy, missense mutations are common in developmental epileptic encephalopathy (DEE) patients. Phenobarbital or carbamazepine may be effective for “benign” variants, while DEE patients often need polytherapy with limited improvement in neurological outcomes [5]. Some patients with Kcnq2 epileptic encephalopathy may respond to pyridoxine treatment [3,6].

In conclusion, Kcnq2 is crucial for stabilizing the neuronal membrane potential through the M-current. Mouse models have been invaluable in understanding the pathological mechanisms of Kcnq2-related epileptic disorders, which can present with a wide range of phenotypes. The study of Kcnq2 provides insights into potential therapeutic strategies for these epilepsy-related diseases.

References:

1. Brun, Lucile, Viemari, Jean-Charles, Villard, Laurent. 2022. Mouse models of Kcnq2 dysfunction. In Epilepsia, 63, 2813-2826. doi:10.1111/epi.17405. https://pubmed.ncbi.nlm.nih.gov/36047730/

2. Ma, Demin, Zheng, Yueming, Li, Xiaoxiao, Gao, Zhaobing, Guo, Jiangtao. 2023. Ligand activation mechanisms of human KCNQ2 channel. In Nature communications, 14, 6632. doi:10.1038/s41467-023-42416-x. https://pubmed.ncbi.nlm.nih.gov/37857637/

3. Chen, Jun, Tao, Qiuji, Fan, Lijuan, Liang, Mengmeng, Gan, Jing. 2022. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review. In Molecular genetics & genomic medicine, 10, e2024. doi:10.1002/mgg3.2024. https://pubmed.ncbi.nlm.nih.gov/35906921/

4. Springer, Kristen, Varghese, Nissi, Tzingounis, Anastasios V. 2021. Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders. In Developmental neuroscience, 43, 191-200. doi:10.1159/000515495. https://pubmed.ncbi.nlm.nih.gov/33794528/

5. Falsaperla, Raffaele, Criscione, Roberta, Cimino, Carla, Pisani, Francesco, Ruggieri, Martino. 2023. KCNQ2-Related Epilepsy: Genotype-Phenotype Relationship with Tailored Antiseizure Medication (ASM)-A Systematic Review. In Neuropediatrics, 54, 297-307. doi:10.1055/a-2060-4576. https://pubmed.ncbi.nlm.nih.gov/36948217/

6. Chow, Chit Kwong, Luk, Ho Ming, Wong, Suet Na. 2020. KCNQ2 Encephalopathy and Responsiveness to Pyridoxal-5'-Phosphate. In Journal of pediatric genetics, 12, 90-94. doi:10.1055/s-0040-1721384. https://pubmed.ncbi.nlm.nih.gov/36684546/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest